IBRUTINIB PLUS BR OR R‐CHOP IN PREVIOUSLY TREATED PATIENTS WITH FOLLICULAR OR MARGINAL ZONE LYMPHOMA: THE PHASE 3 SELENE STUDY

• DOI: 10.1002/hon.3196_lba2
• Publication Date: 2023-06-09T21:19:31Z
• Authors: L. J. Nastoupil; G. Hess; M. A. Pavlovsky; I. Danielewicz; J. Freeman; A. M. García‐Sancho; V. Glazunova; A. Grigg; J. Hou; A. Janssens; S. J. Kim; Z. Masliak; P. McKay; F. Merli; W. Munakata; H. Nagai; M. Özcan; M. Preis; T. Wang; J. Zhu; M. Rowe; R. Qin; T. Henninger; M. Curtis; D. B. Caces; C. Thieblemont; G. Salles